Martin Shkreli - Bio, News, Photos - Washington Times
Skip to content

Martin Shkreli

Latest Stories

martin_shkreli_trial_93439.jpg

martin_shkreli_trial_93439.jpg

Martin Shkreli stands with his attorneys as they talk to reporters in front of federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_43155.jpg

martin_shkreli_trial_43155.jpg

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_34330.jpg

martin_shkreli_trial_34330.jpg

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_97411.jpg

martin_shkreli_trial_97411.jpg

Martin Shkreli, left, and his attorney Benjamin Brafman leave federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_75850.jpg

martin_shkreli_trial_75850.jpg

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_71627.jpg

martin_shkreli_trial_71627.jpg

Martin Shkreli makes a face as his attorney Benjamin Brafman talks about his client's reputation while talking to reporters in front leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

aptopix_martin_shkreli_trial_42064.jpg

aptopix_martin_shkreli_trial_42064.jpg

Martin Shkreli, right, and his attorney Benjamin Brafman, left, leave federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_42064.jpg

martin_shkreli_trial_42064.jpg

Martin Shkreli, right, and his attorney Benjamin Brafman, left, leave federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_51586.jpg

martin_shkreli_trial_51586.jpg

Martin Shkreli, left, talks with reporters while standing next to his attorney Benjamin Brafman after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on Friday on three of eight counts. (AP Photo/Seth Wenig)

martin_shkreli_trial_73128.jpg

martin_shkreli_trial_73128.jpg

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. (AP Photo/Seth Wenig)

martin_shkreli_trial_78968.jpg

martin_shkreli_trial_78968.jpg

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. (AP Photo/Seth Wenig)

martin_shkreli_trial_01657.jpg

martin_shkreli_trial_01657.jpg

Former pharmaceutical CEO Martin Shkreli leaves the U.S. District Court for the Eastern District of New York on Monday, July 31, 2017, in the Brooklyn borough of New York. Jurors finished their first day of deliberations in the federal securities fraud trial of Shkreli without reaching a verdict. They are expected back on Tuesday to continue deliberating on the charges he faces. (AP Photo/Michael Noble Jr.)

martin_shkreli_trial_62860.jpg

martin_shkreli_trial_62860.jpg

Former pharmaceutical CEO Martin Shkreli leaves the U.S. District Court for the Eastern District of New York on Monday, July 31, 2017, in the Brooklyn borough of New York. Jurors finished their first day of deliberations in the federal securities fraud trial of Shkreli without reaching a verdict. They are expected back on Tuesday to continue deliberating on the charges he faces. (AP Photo/Michael Noble Jr.)

martin_shkreli_trial_67524.jpg

martin_shkreli_trial_67524.jpg

Former pharmaceutical CEO Martin Shkreli leaves the U.S. District Court for the Eastern District of New York on Monday, July 31, 2017, in the Brooklyn borough of New York. Jurors finished their first day of deliberations in the federal securities fraud trial of Shkreli without reaching a verdict. They are expected back on Tuesday to continue deliberating on the charges he faces. (AP Photo/Michael Noble Jr.)

martin_shkreli_trial_88298.jpg

martin_shkreli_trial_88298.jpg

Former pharmaceutical CEO Martin Shkreli leaves the U.S. District Court for the Eastern District of New York on Monday, July 31, 2017, in the Brooklyn borough of New York. Jurors finished their first day of deliberations in the federal securities fraud trial of Shkreli without reaching a verdict. They are expected back on Tuesday to continue deliberating on the charges he faces. (AP Photo/Michael Noble Jr.)

martin_shkreli_trial_81425.jpg

martin_shkreli_trial_81425.jpg

Former pharmaceutical CEO Martin Shkreli leaves the U.S. District Court for the Eastern District of New York on Monday, July 31, 2017, in the Brooklyn borough of New York. Jurors finished their first day of deliberations in the federal securities fraud trial of Shkreli without reaching a verdict. They are expected back on Tuesday to continue deliberating on the charges he faces. (AP Photo/Michael Noble Jr.)

martin_shkreli_trial_15364.jpg

martin_shkreli_trial_15364.jpg

FILE- In this June 19, 2017 file photo, former Turing Pharmaceuticals CEO, Martin Shkreli, center, arrives at Brooklyn federal court in New York with members of his legal team. Jurors heard testimony from the government's last witness on Tuesday, July 25, 2017, a day after Shkreli's lawyer told the court his client won't take the witness stand during his securities fraud trial. (AP Photo/Mark Lennihan, File)

martin_shkreli_trial_05886.jpg

martin_shkreli_trial_05886.jpg

FILE - In this Feb. 3, 2016, file photo, former biotech CEO Martin Shkreli. Jurors heard testimony from the government's last witness on Tuesday, July 25, 2017, a day after Shkreli's lawyer told the court his client won't take the witness stand during his securities fraud trial. (AP Photo/Seth Wenig, File)

martin_shkreli_trial_34718.jpg

martin_shkreli_trial_34718.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

martin_shkreli_trial_02674.jpg

martin_shkreli_trial_02674.jpg

Former Turing Pharmaceuticals CEO Martin Shkreli arrives to federal court in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)